DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - NEVRO CORP ownership

NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 19 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2022$39,609,000
-31.4%
42,000,000
-31.1%
0.79%
-33.8%
Q2 2022$57,724,000
-11.7%
61,000,0000.0%1.19%
-18.5%
Q1 2022$65,368,000
-4.1%
61,000,0000.0%1.46%
+2.2%
Q4 2021$68,194,000
+95.5%
61,000,000
+134.6%
1.43%
+110.0%
Q3 2021$34,876,000
+67.2%
26,000,000
+116.7%
0.68%
+83.6%
Q2 2021$20,863,000
+14.6%
12,000,0000.0%0.37%
-3.1%
Q1 2021$18,208,000
-16.9%
12,000,0000.0%0.38%
-11.5%
Q4 2020$21,915,000
+16.7%
12,000,0000.0%0.43%
-5.3%
Q3 2020$18,784,000
+14.3%
12,000,0000.0%0.46%
-4.6%
Q2 2020$16,438,00012,000,0000.48%
Other shareholders
NEVRO CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 9,000,000$135,324,0001.71%
DeepCurrents Investment Group LLC 21,930,000$33,750,0001.16%
WOLVERINE ASSET MANAGEMENT LLC 44,534,000$69,564,0000.59%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 12,000,000$18,208,0000.38%
Context Capital Management, LLC 2,000$3,084,0000.30%
ZAZOVE ASSOCIATES LLC 1,500,000$2,276,0000.27%
Polar Asset Management Partners Inc. 17,500,000$26,683,0000.26%
CSS LLC/IL 2,500,000$3,780,0000.16%
Verition Fund Management LLC 7,486,000$11,543,0000.13%
PFM Health Sciences, LP 2,000,000$3,032,0000.09%
View complete list of NEVRO CORP shareholders